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Health beliefsIntroduction: Decisions about influenza vaccination for fall-winter 2020 were made against the backdrop
of the COVID-19 pandemic. During May 2020, the authors examined intended vaccination in the next
12 months in relationship to demographic variables, healthcare attitudes, and personal COVID-19 expe-
riences for two samples of adults--those who did not receive influenza vaccine during the prior
12 months, and those who did.
Methods: In May 2020, a cross-sectional online survey was conducted with a national US sample.
Participants reported prior influenza vaccination (yes/no during prior 12 months) and anticipated vacci-
nation (yes/no during next 12 months). Covariates included demographic characteristics (e.g., gender,
race-ethnicity, political ideology), general beliefs (e.g., benefits of vaccines, altruistic attitudes), and
COVID-19 health beliefs and experiences (COVID-19 worry and severity, perception of COVID-19 as a
community threat, knowing someone with COVID-19). For each group, hierarchical multivariable logistic
regression was conducted with intent to vaccinate as the outcome.
Results: Among participants (n = 3502), 47% did not receive influenza vaccine in the prior 12 months and
53% had; 25.5% of non-vaccinators and 91.9% of vaccinators intended future vaccination. For non-
vaccinators, odds of intending vaccination was associated with race/ethnicity (Hispanics were more likely
to intend than white-NH; AOR = 1.74; 95% CI = 1.23–2.4), greater perceived benefits of vaccination
(AOR = 2.19; 95% CI = 1.88–2.54), and perception of COVID-19 as a community threat (AOR = 1.91;
95% CI = 1.49–2.45). For vaccinators, odds of intending vaccination was associated with age
(AOR = 1.04; 95% CI = 1.03–1.05), race/ethnicity (Black-NH and Other-NH were less likely to intend than
white-NH, AOR = 0.60; 95% CI = 0.36–0.999; and AOR = 0.45; 95% CI = 0.24–0.84, respectively), greater
perceived benefits of vaccination (AOR = 1.88; 95% CI = 1.45–2.45) and greater perception of collective
benefits of vaccines (AOR = 1.48; 95% CI = 1.15–1.90).
Conclusions: The COVID-19 pandemic may have served as a cue to action for influenza vaccination inten-
tion among some prior non-vaccinators whereas intention among prior vaccinators is more related to
positive attitudes toward vaccination.
 2021 Published by Elsevier Ltd.1. Introduction
The CDC estimated that from October 1, 2019 through April 4,
2020 there were 410,000–740,000 influenza-related hospitaliza-
tions and 24,000–62,000 influenza deaths in the United States[1]. High influenza vaccine coverage can reduce related mortality,
but influenza vaccine coverage is routinely low for adults with only
45% receiving a vaccination for the 2018–2019 influenza season
[2]. Such coverage rates stem in part from the public’s worries
about lower efficacy, the need for yearly vaccination, and more
potential side effects than other vaccines [3]. Views of influenza
vaccine as different from other vaccines apply to adults and chil-
dren [3–5]. Anticipating co-circulation of COVID-19 and influenza
in fall-winter 2020–2021, [6,7] public health experts advocated
for high influenza vaccine coverage to both help reduce morbidityaccine,
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influenza and COVID-19 illnesses), and to preserve health system
capacity for responding to the pandemic [6].
Prior influenza vaccination behavior is a strong predictor of
future influenza vaccine acceptance [8,9] which did not bode well
for increased coverage in the 2020–2021 influenza season. Indeed,
vaccine uptake among the general population during the world-
wide H1N1 pandemic in 2009 was very low, with many countries
reporting less than 50% of expected coverage. However, individuals
who received influenza vaccine in the prior season had higher vac-
cine uptake during the pandemic [8].
The public’s decision-making about influenza vaccination for
the 2020–21 influenza season was necessarily made in the context
of the ongoing COVID-19 pandemic. Given that COVID-19 is a res-
piratory illness, some of whose symptoms and mode of transmis-
sion resemble those of influenza [7], the public’s perceptions of
COVID-19 may have impacted their willingness to vaccinate
against influenza. This project examined two groups of adults:
those who did not receive an influenza vaccine in the past twelve
months (prior to the COVID-19 pandemic) and those who did
receive the vaccine, and assessed their intentions prior to the
2020–2021 influenza season to receive an influenza vaccine in
the upcoming twelve months (concurrent with the COVID-19 pan-
demic). We also explored whether intention to vaccinate in the
upcoming year was associated in each group with different demo-
graphic variables, health-related beliefs and attitudes, and reports
and perceptions of ongoing experiences with COVID-19.2. Methods
2.1. Study sample
An online survey assessing knowledge, beliefs and behaviors
related to the COVID-19 pandemic was programmed using the sur-
vey program Qualtrics. It was distributed to participants through
Dynata, a market research firm that manages recruitment of survey
respondents from panels which include 31 million volunteer sur-
vey respondents throughout North America. Data were collected
from May 4 to May 11, 2020, and analyzed in June 2020. Panel
members receive monetary incentives from Dynata for participa-
tion. Email invitations were sent to members of the U.S. panel
who fit study eligibility criteria of being 18 years or older and able
to read English. Dynata balanced recruitment to be reflective of
national census data with respect to age, gender, race/ethnicity,
and state of residence. This study was granted exempt status by
Indiana University’s Institutional Review Board.2.2. Measures
A single item measured participants’ reports of influenza vac-
cine receipt during the prior 12 months, with response options
yes and no. A separate single itemmeasured participants’ intention
to receive the influenza vaccine in the next 12 months, with
response options yes and no.
Regarding demographic characteristics, respondents provided
information about their age, gender, educational attainment,
household income, race/ethnicity, U.S. region of residence, and
political ideology. Political ideology was a single item question,
‘‘In general, how would you describe your political views?‘‘, with
response options of very liberal, liberal, moderate/middle of the
road, conservative, and very conservative. For purposes of analysis,
we collapsed responses into three categories: liberal, moderate/
middle of the road, and conservative.
General belief measures included attitudes about vaccines and
altruistic attitudes that might predispose a respondent to decide2
to engage in vaccination. Benefits of vaccination was a four-item
scale assessing positive regard for vaccines (e.g., ‘‘Vaccines are a
way to take good care of myself now and in the future”; ‘‘Vaccines
are effective”) adapted from prior research on attitudes about vac-
cination [10,11]. Items were rated with a Likert-type response
scale ranging from 1 = strongly disagree to 5 = strongly agree. Items
were summed and averaged to create a single score (coefficient
alpha = 0.92). Collective benefits of vaccines reflected the potential
for personal vaccination to benefit the collective community. This
measure consisted of two items, i.e., ‘‘I get vaccinated because I
can also protect people with a weaker immunity”; and ‘‘Vaccina-
tion is a collective action to prevent spread of diseases”; which
were adapted from prior research (coefficient alpha = 0.81) [12].
These items also were rated with a Likert-type response scale rang-
ing from 1 = strongly disagree to 5 = strongly agree.
A previously validated 18-item altruism scale [13] was modified
and consisted of 18 questions assessing how frequently the partic-
ipant engaged in various altruistic activities (e.g., helping a stran-
ger push their car out of the snow or mud) on a Likert-type scale
from 1 = never to 5 = very often. A principal components explora-
tory factor analysis extracted two factors which we labeled high
commitment altruism and low commitment altruism. High com-
mitment altruism consisted of five items (Cronbach alpha = 0.83)
and included behaviors that necessitated a high level of personal
involvement (e.g., ‘‘I have helped carry a stranger’s belongings
(books, packages, groceries, etc.)”). Low commitment altruism con-
sisted of four items (Cronbach alpha = 0.81) and involved behaviors
requiring a low level of personal involvement (e.g., ‘‘I have given
money to charity”). A mean score was calculated for each subscale.
COVID-19 health beliefs included COVID-related worry, per-
ceived severity of COVID-19, knowing someone who has been
infected, and perceived threat of COVID-19 in their community.
During pretesting of the survey, and in line with the more common
usage of COVID-19 being used by the lay public, all questions
included the phrase COVID-19 rather than SARS-CoV-2 when ask-
ing about both the virus and disease. COVID-19-related worry was
measured with a three-item scale that probed worry about becom-
ing infected with COVID-19 (e.g., ‘‘The possibility of getting
infected in the future with COVID-19 concerns me”). These items
were adapted from previous research on worries about HIV infec-
tion [14,15]. Response options ranged from 1 = strongly disagree to
5 = strongly agree. The three items were summed and averaged
into a single scale score, with higher scores indicating higher
COVID-19-related worry (Cronbach alpha = 0.82). Perceived sever-
ity of COVID-19 was assessed using a four-item scale adapted from
the literature on the Ebola outbreak [16] which assessed partici-
pants’ perceptions of the severity of COVID-19 disease (e.g., ‘‘I am
afraid that I may die if I contract COVID-19”). Response options
ranged from 1 = strongly disagree to 5 = strongly agree. The four
items were summed and averaged to derive a single perceived
severity score (Cronbach alpha = 0.71), with higher scores reflect-
ing higher perceived severity. Knowing someone infected was
assessed with a single item ‘‘Do you know anyone who has had
COVID-19?” Response options were: yes; I believe so but awaiting
results; and no. Perceived community threat consisted of a single
item ‘‘Do you think COVID-19 infection is a major problem in your
community?” with a binary yes/no response option.
2.3. Analysis
We first distinguished between participants who had and had
not received the influenza vaccination in the past twelve months.
Using means and standard deviations or percentages, we described
the sample characteristics of the non-vaccinator and vaccinator
subsamples. Sample sizes vary across variables due to some
respondents declining to answer specific items. For this study,
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12 months (yes/no). For both subsamples, vaccinators and non-
vaccinators, we initially used bivariate logistic regression to exam-
ine the association of demographic variables, vaccine attitudes,
altruism, and COVID-19-specific experiences and health beliefs
with intent to be vaccinated. Any variable that was significant at
p < .01 in bivariate comparisons was included in a subsequent hier-
archical multivariable regression model with intent to vaccinate in
the next 12 months as the outcome. This threshold for significance
was chosen because a cutoff of p < .05 would have led to the inclu-
sion of covariates with very small effect sizes due the relatively
large sample size. Variables entered in step 1 were demographic
and background variables. Variables entered in step 2 were general
beliefs and vaccine attitudes that might predispose a respondent to
vaccinate, including doing so on behalf of others’ wellbeing. Vari-
ables entered in step 3 were COVID-19-specific experiences and
beliefs. We then created a reduced model with p < .05 needed for
a variable to remain in the model.3. Results
A total of 4,042 respondents opened the survey, 351 declined
participation, and 42 were younger than 18 years old and excluded.
The survey was completed by 3,586 participants, and of these,
3,502 answered all the questions about both prior influenza vacci-
nation and future influenza vaccine intention and were included in
the statistical analyses. The past non-vaccinator group consisted of
1,652 respondents (47% of total sample); the majority (74.5%) of
these past non-vaccinators did not intend to get the vaccine in
the next 12 months (non-intender subsample) but 25.5% did
intend (intender subsample). Of the prior vaccinators (n = 1850,
53% of total sample), 91.9% intended to be vaccinated and 8.1%
did not intend to get vaccinated. Overall, those who received the
influenza vaccine in the past year were significantly more likely
to intend vaccination in the upcoming year (chi-square = 1,608.8
6, p < .001). The remainder of analyses focus on the non-
vaccinator and vaccinator subsamples separately.3.1. Non-vaccinators
Table 1 summarizes sample characteristics and bivariate com-
parisons, including percentages intending to receive an influenza
vaccine in the next 12 months (for categorical variables) and point
bi-serial correlations (for continuous variables). The mean sample
age was 42.9 years and there were more females than males
(53.6%, 45.9%, respectively). The majority (62%) were white non-
Hispanic (NH), 17.4% were Black NH, 7.3% other-NH and 13.3% His-
panic. Most participants (71.2%) had some post-high school educa-
tion, and 28.8% had high school completion or less. Geographic
location spanned the US with slightly more residing in the South-
east (26.9%) and Midwest (22.2%) than in the Northeast (17.9%) or
Southwest (11.1%) areas. Nearly 40% of respondents self-identified
as having moderate political leanings (39.9%), with 30.8% identify-
ing as liberals and 29.3% identifying as conservatives. The majority
of this sample (68.8%) reported not knowing someone infected
with COVID-19 and slightly more than half (52.2%) considered
COVID-19 to be a major problem in their community.
In bivariate comparisons, two demographic characteristics dif-
fered at p < .01 between intenders and non-intenders: race/ethnic-
ity and political ideology. Compared to white-NH respondents,
Hispanic respondents had increased odds of future vaccination
intention (OR = 1.89; 95%CI = 1.38–2.58). Compared to self-
identified liberals, conservatives had about half the odds of intend-
ing future vaccination (OR = 0.51; 95% CI = 0.38-0.69). Age, educa-
tion, and household income were significant at the p < .05 level but3
did not meet the p < .01 significance threshold for inclusion in the
subsequent hierarchical logistic regression analysis (see Table 1 for
complete bivariate results).
All general vaccine beliefs were positively associated with
intention for future vaccination at the p < .01 level: benefits of vac-
cination (OR = 2.18; 95%CI = 1.90–2.51), collective benefits of vac-
cines (OR = 1.82; 95%CI = 1.60–2.07), high commitment altruism
(OR = 1.29; 95%CI = 1.15–1.46), and low commitment altruism
(OR = 1.34; 95%CI = 1.18–1.52). COVID-19 specific measures were
also predictive: higher levels of COVID-19 worry (OR = 1.52; 95%
CI = 1.35–1.70) and COVID-19 severity (OR = 1.48; 95%CI = 1.29–
1.70) were both related to intention to vaccinate. Compared to
those who did not know someone infected with COVID-19, those
who reported yes or not sure had higher odds of intending to get
vaccinated (OR = 1.37; 95%CI = 1.05–1.79; and OR = 1.89; 95%
CI = 1.32–2.70, respectively). Compared to participants who did
not perceive COVID-19 to be a problem in their community, those
who did report this perception had greater odds of intending future
vaccination (OR = 2.37; 95%CI = 1.87–3.00).
Table 2 summarizes the multivariable hierarchical logistic
regression analysis and the reduced model. In Step 1, the demo-
graphic and background variables, race/ethnicity and political ide-
ology were entered and remained significant covariates. In Step 2,
the general beliefs, perceived benefits of vaccination, collective
benefits of vaccines, high commitment altruism, and low commit-
ment altruism were entered. Of these, only perceived benefits of
vaccination remained significant and political ideology became
non-significant. In Step 3, the COVID-19-related measures, per-
ceived community threat, COVID-19 worry, COVID-19 severity,
and knowing someone infected were entered. Of these, only per-
ceived community threat of COVID-19 remained significant. For
the reduced model, odds of being in the intender group was asso-
ciated with race/ethnicity, benefits of vaccination, and perceived
community threat. Specifically, compared to White respondents,
Hispanic respondents had increased odds of being in the intender
group (AOR = 1.74; 95%CI = 1.23–2.44, p < .01). Higher perceived
benefits of vaccination (AOR = 2.19; 95%CI = 1.88–2.54) and per-
ceived community threat (AOR = 1.91; 95%CI = 1.49–2.45) were
both associated with greater odds of being an intender.
3.2. Vaccinators
Table 3 summarizes sample characteristics and bivariate com-
parisons, including percentages intending to receive an influenza
vaccine in the next 12 months (for categorical variables) and point
bi-serial correlations (for continuous variables). The mean sample
age was 48.2 years and there was an equal split between males
and females (49.2% and 50.7%). The majority (64.9%) were white-
NH, 14.3% were Hispanic, 13.1% were Black-NH and 7.7% were
Other-NH. Educational attainment was fairly evenly distributed,
with the least number (19%) reporting high school completion or
less. Household income was evenly distributed across the four cat-
egories, with a smaller percentage reporting more than $150,000
per year. Geographic location spanned the United States, with
slightly fewer participants residing in the Southwest (10.7%).
Respondents slightly more often self-identified as having moderate
political leanings (36.7%) and there was a comparable representa-
tion of liberals (32.6%) and conservatives (30.7%) The majority of
this sample (62.2%) reported not knowing someone infected with
COVID-19 and a similar proportion (62.7%) felt that COVID-19
was a major problem in their community.
In bivariate comparisons, three demographic characteristics dif-
fered at p < .01 between intenders and non-intenders: age, race/
ethnicity and education. As age increased, the odds of intending
future vaccination increased (r = 0.246, OR = 1.06 ;95% CI = 1.05–
1.07). Odds of future vaccination also increased with any level of
Table 1
Intention to Receive Influenza Vaccine among Prior Non-Vaccinators: Descriptive Statistics and Binary Logistic Regression Results.
% (n) Or Mean (SD) Intention to get Flu Vaccine in Next








Age 42.94 (15.18) r = -0.06 0.99 (0.98–0.99)*
Sex
Female 53.6% (882) 25.9% Ref
Male 45.9% (754) 24.7% 0.94 (0.75–1.18)
Other 0.5% (8)
Race/Ethnicity
White-NH 62.0% (1,011) 23.6% Ref
Black-NH 17.4% (283) 23.0% 0.96 (0.70–1.32)
Other-NH 7.0.3% (119) 27.7% 1.24 (0.81–1.90)
Hispanic 13.3% (217) 36.9% 1.89 (1.38–2.58)**
Education
HS Grad or Less 28.8% (469) 23.7% Ref
Some College 30.7% (501) 23.0% 0.96 (0.71–1.29)
Bachelor’s 26.2% (427) 30.0% 1.38 (1.03–1.86)*
Grad School 14.3% (234) 26.5% 1.16 (0.81–1.67)
Income
< $25,000 38.2% (612) 23.4% Ref
$25,000-$75,000 30.0% (482) 24.5% 1.06 (0.80–1.41)
$75,000-$150,000 23.6% (378) 29.4% 1.36 (1.02–1.82)*
>$150,000 8.2% (132) 28.8% 1.33 (0.87–2.02)
US Region
Northeast 17.9% (293) 27.0% Ref
Southeast 26.9% (441) 25.4% 0.92 (0.66–1.29)
Midwest 22.2% (364) 21.7% 0.75 (0.52–1.08)
Southwest 11.1% (181) 31.5% 1.24 (0.83–1.87)
West 21.9% (359) 24.2% 0.87 (0.61–1.23)
Political Leanings
Liberal 30.8% (471) 32.3% Ref
Moderate 39.9% (610) 25.7% 0.73 (0.56–0.95)*
Conservative 29.3% (448) 19.6% 0.51 (0.38–0.69)**
General Beliefs:
Benefits of Vaccination 3.54 (0.99) r = 0.28 2.18 (1.90–2.51)**
Collective Benefits of Vaccines 3.55 (1.03) r = 0.23 1.82 (1.60–2.07)**
High Commitment Altruism 2.44 (0.92) r = 0.10 1.29 (1.15–1.46)**
Low Commitment Altruism 3.20 (0.93) r = 0.11 1.34 (1.18–1.52)**
COVID-19 Measures:
COVID-19 Worry 3.29 (1.10) r = 0.18 1.52 (1.35–1.70)**
COVID-19 Severity 2.90 (0.86) r = 0.14 1.48 (1.29–1.70)**
Know Someone Infected
No 68.8% (1,127) 22.9% Ref
Yes 21.9% (359) 29.0% 1.37 (1.05–1.79)*
Not Sure 9.3% (153) 35.9% 1.89 (1.32–2.70)**
COVID-19 a Problem in your Community
No 47.8% (779) 17.1% Ref
Yes 52.2% (851) 32.8% 2.37 (1.87–3.00)**
*p < .05, **p < .01.
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39–3.50 for some college; OR = 2.68 ;95% CI = 1.69–4.24 for Bach-
elor’s degree; OR = 2.46; 95% CI = 1.51–4.03 for graduate educa-
tion.) Compared to white respondents, all other groups had
decreased odds of vaccination intention (Black-NH OR = 0.24;
95% CI = 0.16-0.037; Other-NH OR = 0.28; 95% CI = 0.16–0.48; His-
panic OR = 0.32; 95%CI = 0.20–0.51).
Of the general beliefs, higher levels of benefits of vaccination
(r = 0.33; OR = 3.05; 95%CI = 2.55–3.66), collective benefits of vac-
cines (r = 0.29, OR = 2.44; 95% CI = 2.08–2.88), and low commit-
ment altruism (r = 0.12, OR = 1.61; 95% CI = 1.34–1.93) predicted
greater vaccination intention. Of the COVID-19 measures, higher
levels of COVID-19 worry and severity were related to greater vac-
cination intention (r = 0.10, OR = 1.39; 95%CI = 1.17–1.64 and
r = 0.05, OR = 1.26; 95%CI = 1.02–1.56, respectively). Compared4
to those who did not know someone infected with COVID-19, those
who reported yes or not sure were less likely to intend vaccination
(OR = 0.64; 95%CI = 0.44–0.93 and OR = 0.49; 95%CI = 0.30–0.80,
respectively).
Table 4 summarizes the multivariable hierarchical logistic
regression analysis and the reduced model. In Step 1, the demo-
graphic and background variables were entered, and age, race/eth-
nicity, and education remained significant covariates. In Step 2, the
general beliefs were entered, and benefits of vaccination and col-
lective benefits of vaccines were significant. In Step 3, three
COVID-19-related measures, COVID-19 worry, perceived commu-
nity threat, and knowing someone infected were entered and none
were significant. For the reduced model, odds of being in the inten-
der group was associated with age, race/ethnicity, benefits of vac-
cination, and collective benefits of vaccines. Specifically, greater
Table 2
Intention to Receive Influenza Vaccine among Prior Vaccinators: Descriptive Statistics and Binary Logistic Regression Results.
% (n) Or Mean (SD) Intention to get Flu Vaccine in Next








Age 48.2 (17.9) r = 0.246 1.06 (1.05–1.07)**
Sex
Female 50.7% (934) 91.4% Ref
Male 49.2% (907) 92.5% 1.16 (0.82–1.62)
Other 0.1% (2)
Race/Ethnicity
White-NH 64.9% (239) 95.5% Ref
Black-NH 13.1% (1,186) 83.7% 0.24 (0.16–0.37)**
Other-NH 7.7% (140) 85.7% 0.28 (0.16–0.48)**
Hispanic 14.3% (262) 87.4% 0.32 (0.20–0.51)**
Education
HS Grad or Less 19.0% (347) 85.6% Ref
Some College 26.3% (480) 92.9% 2.21 (1.39–3.50)**
Bachelor’s 31.5% (575) 94.1% 2.68 (1.69–4.24)**
Grad School 23.1% (422) 93.6% 2.46 (1.51–4.03)**
Income
< $25,000 25.6% (462) 90.3% Ref
$25,000-$75,000 31.1% (561) 91.3% 1.13 (0.74–1.72)
$75,000-$150,000 30.9% (558) 93.4% 1.52 (0.96–2.39)
>$150,000 12.5% (225) 93.3% 1.51 (0.82–2.77)
US Region
Northeast 22.8% (417) 92.1% Ref
Southeast 25.5% (466) 94.2% 1.40 (0.82–2.37)
Midwest 21.5% (393) 90.3% 0.80 (0.49–1.31)
Southwest 10.7% (196) 88.8% 0.68 (0.38–1.20)
West 19.6% (359) 92.8% 1.10 (0.64–1.88)
Political Leanings
Liberal 32.6% (574) 91.5% Ref
Moderate 36.7% (645) 93.2% 1.28 (0.84–1.95)
Conservative 30.7% (540) 93.3% 1.31 (0.84–2.04)
General Beliefs:
Benefits of Vaccination 4.18 (0.85) r = 0.33 3.05 (2.55–3.66)**
Collective Benefits of Vaccines 4.16 (0.90) r = 0.29 2.44 (2.08–2.878)**
High Commitment Altruism 2.61 (0.96) r = -0.02 0.93 (0.78–1.10)
Low Commitment Altruism 3.56 (0.86) r = 0.12 1.61 (1.34–1.93)**
COVID-19 Measures:
COVID-19 Worry 3.63 (1.05) r = 0.10 1.39 (1.17–1.64)**
COVID-19 Severity 3.14 (0.88) r = 0.05 1.26 (1.02–1.56)*
Know Someone Infected
No 62.2% (1,132) 93.5% Ref
Yes 27.7% (505) 90.1% 0.64 (0.44–0.93)*
Not Sure 10.1% (184) 87.5% 0.49 (0.30–0.80)**
COVID_19 a Problem in your Community
No 37.3% (679) 90.9% Ref
Yes 62.7% (1,142) 92.8% 1.30 (0.92–1.83)
*p < .05, **p < .01.
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(AOR = 1.04; 95% CI = 1.03–1.05). Compared to White respondents,
Black-NH and Other-NH respondents had decreased odds of being
in the intender group (AOR = 0.60; 95%CI = 0.36-0.999, p < .05 and
AOR = 0.45; 95%CI = 0.24-0.84, respectively). Higher perceived ben-
efits of vaccination (AOR = 1.88; 95%CI = 1.45–2.45) and perceived
community threat (AOR = 1.48; 95%CI = 1.15–1.90) were both asso-
ciated with greater odds of intending vaccination.4. Discussion
The purpose of this study was to assess the relationship
between individuals’ past influenza vaccination behavior and their
current intentions to receive the influenza shot in the next twelve
months, as well as to assess the relationship between intention,
health-related beliefs and attitudes, and perceptions of ongoing
experiences with COVID-19. Of participants who were not vacci-5
nated against influenza in the prior year, 25.5% shifted their stance
to intend vaccination in the upcoming 12 months; the overwhelm-
ing majority of prior vaccinators (91.9%) planned to be vaccinated
again and a small subgroup (8.1%) no longer intended to vaccinate.
Considering this subgroup who ‘‘flipped” from prior vaccinator to
non-intender, additional qualitative studies (e.g., individual inter-
views or focus groups) may identify the reasons for refusals. It is
possible that a certain percentage may have vaccinated in the past
because it was a condition of their employment (e.g., in health care
settings), but may have lost their jobs and no longer felt a need to
vaccinate. Our finding that a subgroup of non-vaccinators intend to
vaccinate is consistent with a recent multi-country study of par-
ents’ intention to vaccinate their children against influenza in the
upcoming season: 28.6% of prior non-vaccinators intended to vac-
cinate in the upcoming year [17]. Together, our findings-- that a
sizeable proportion of adults who had not been vaccinated in the
prior year and most prior vaccinators intended to be vaccinated
Table 3











White-NH Ref Ref Ref Ref
Black-NH 0.93 (0.66–1.33) 1.34 (0.92–1.96) 1.28 (0.88–1.88) 1.13 (0.80–1.59)
Other-NH 1.26 (0.78–2.02) 1.75 (1.06–2.89)* 1.66 (1.004–2.75)* 1.51 (0.96–2.39)
Hispanic 1.77 (1.23–2.54)** 2.12 (1.44–3.14)** 1.96 (1.32–2.91)** 1.74 (1.23–2.44)**
Political Leanings
Liberal Ref Ref Ref
Moderate 0.85 (0.63–1.13) 1.06 (0.78–1.44) 1.13 (0.83–1.54)
Conservative 0.57 (0.40–0.79)** 0.77 (0.54–1.11) 0.90 (0.62–1.30)
General Beliefs:
Benefits of Vaccination 2.01 (1.61–2.51)** 1.98 (1.58–2.47)** 2.19 (1.88–2.54)**
Collective Benefits of Vaccines 1.16 (0.95–1.42) 1.10 (0.90–1.35)
High Commitment Altruism 1.13 (0.95–1.34) 1.09 (0.92–1.30)
Low Commitment Altruism 1.17 (0.97–1.41) 1.18 (0.97–1.43)
COVID-19 Measures:
COVID-19 Worry 1.07 (0.90–1.27)




Not Sure 1.57 (0.98–2.50)
COVID-19 a Problem in your Community
No Ref Ref
Yes 1.47 (1.10–1.97)** 1.91 (1.49–2.45)**
*p < .05, **p < .01.
Table 4










Age 1.05 (1.04–1.07)** 1.04 (1.02–1.06)** 1.04 (1.02–1.06)** 1.04 (1.03–1.05)**
Race/Ethnicity
White- NH Ref Ref Ref Ref
Black-NH 0.42 (0.25–0.73)** 0.54 (0.30–0.99)* 0.56 (0.30–1.02) 0.60 (0.36–0.999)*
Other-NH 0.42 (0.22–0.80)** 0.42 (0.21–0.87)* 0.43 (0.21–0.89)* 0.45 (0.24–0.84)*
Hispanic 0.69 (0.38–1.25) 0.82 (0.43–1.56) 0.79 (0.41–1.52) 0.92 (0.54–1.57)
Education
HS Grad or Less Ref Ref Ref
Some College 1.49 (0.85–2.61) 1.75 (0.96–3.21) 1.81 (0.98–3.34) 1.54 (0.91–2.61)
Bachelor’s 2.52 (1.38–4.63)** 2.57 (1.32–5.01)** 2.62 (1.34–5.12)** 1.67 (0.99–2.81)
Grad School 1.44 (0.81–2.56) 1.45 (0.76–2.76) 1.44 (0.76–2.73) 1.62 (0.93–2.85)
General Beliefs:
Benefits of Vaccination 2.54 (1.84–3.50)** 2.52 (1.82–3.50)** 1.88 (1.45–2.45)**
Collective Benefits of Vaccines 1.47 (1.08–2.01)* 1.47 (1.08–2.01)* 1.48 (1.15–1.90)**
Low Commitment Altruism 0.92 (0.70–1.20) 0.93 (0.71–1.22)
COVID-19 Measures:




Not Sure 0.92 (0.45–1.87)
COVID_19 a Problem in your Community
No Ref
Yes 1.31 (0.80–2.15)
*p < .05, **p < .01.
L. Sturm, M.L. Kasting, K.J. Head et al. Vaccine xxx (xxxx) xxxin the next year-- are cause for cautious optimism for improving
influenza vaccination uptake during future influenza seasons that
coincide with a viral pandemic.4.1. Attitudes, beliefs, and COVID-19 related experiences
Some differences between the two sets of predictive analyses
emerged. For prior non-vaccinators, positive attitudes about bene-
fits of vaccination and perceiving COVID-19 to be a problem in6
their community increased the odds of future vaccination inten-
tion. Perceiving COVID-19 as a problem in one’s community may
represent perceived threat from the infection that is proximal to
the respondent’s community, in contrast to more distal perceived
threat to the ‘‘nation” as a whole. Drawing on the Health Belief
Model [18], we hypothesize that for some adults who previously
did not vaccinate for influenza, the current COVID-19 health crisis
may serve as a ‘‘cue to action” for influenza vaccination. Cues to
action comprise both internal and environmental triggers that acti-
L. Sturm, M.L. Kasting, K.J. Head et al. Vaccine xxx (xxxx) xxxvate individuals to engage in health promoting behaviors. For prior
non-vaccinators the perception of COVID-19 being a major prob-
lem in their community may have served as such a trigger. Design-
ing public health messages that brings the COVID-19 threat ‘‘closer
to home” and/or appeal to the public’s attachment to their commu-
nity may be a direction for future health communication research
that targets prior non-vaccinators.
For prior vaccinators, intention was unrelated to COVID-19
related experiences and attitudes and it was related to positive
attitudes about benefits of vaccination and vaccination’s collective
benefits. Interestingly, compared to those who did not know some-
one infected with COVID-19, those who reported yes or not sure
were less likely to intend vaccination. In future research it will
be important to query the severity of symptoms of the individuals
whom respondents identified as having COVID-19 (or were not
sure about). Familiarity with non-symptomatic cases and/or mildly
symptomatic cases (e.g., did not require hospitalization) may have
dampened any ‘‘cue to action” effect of COVID-19 related experi-
ence. Overall, public health messages that target general benefits
of vaccination may appeal to both non-vaccinators and vaccinators
alike. Prior vaccinators may also respond to messages reminding
them of the collective benefits of vaccination.
4.2. Sociodemographic analyses
Among past non-vaccinators, compared to white respondents,
being Hispanic increased the odds of being in the intender group;
among vaccinators, Black-NH and Other-NH adults were less likely
than white-NH adults to intend vaccination and older respondents
were more likely than their younger counterparts. Our findings
suggest that the pandemic may have shifted the racial distribution
in influenza vaccination intention [19–21]. For Hispanic respon-
dents who did not vaccinate in the prior year, the current
COVID-19 pandemic may have served as a ‘‘cue to action” that acti-
vated intent to vaccinate against influenza. As Schmid et al. (2017)
note, ethnicity variables are most likely ‘‘carrier variables” of more
complex explanatory factors that may help identify target groups
for intervention but not the content of the interventions them-
selves [8]. Further investigation is needed to unpack factors under-
lying the ethnic difference findings in this study.
The COVID-19 pandemic is not over, and the start of another
influenza season is less than a year away. Understanding how
the COVID-19 pandemic influences influenza vaccination contin-
ues to be important for planning for future public health cam-
paigns. The combination of influenza and a pandemic virus such
as COVID-19 may pose an unprecedented challenge for the health
of the public and a strain on health care systems, including hospital
capacity [6]. As the public may vary in their awareness of the
potential for influenza to intersect with viruses such as COVID-
19, public health messaging should include basic education about
such potential ‘‘perfect storms”. Ongoing public health monitoring
of US adults’ intentions to receive the influenza vaccine during a
pandemic is important, given the potential for changes in percep-
tions of both specific pandemic-related vaccines under develop-
ment and existing vaccines for influenza and other pathogens.
Public health professionals must work to alleviate strain on the
healthcare system while they work to keep individuals healthy
with known measures like an influenza vaccine. The work pre-
sented here offers practical starting points for potential interven-
tion strategies to ensure high influenza vaccine coverage in
seasons to come.
4.3. Limitations
Several limitations to this study are acknowledged. The
question about COVID-19 being a problem in the respondent’s7
community did not define ‘‘community”; thus, geographic and/or
neighborhood referents may vary across respondents. Better delin-
eation of what ‘‘community” means to respondents (e.g., immedi-
ate neighborhood, circle of family/friends, city, county, state, etc.)
may provide ideas for tailoring health messages about immuniza-
tion. An additional limitation of the design was the necessary reli-
ance on intention rather than vaccination behavior; data was
collected in May 2020, prior to the fall-winter influenza vaccina-
tion season. Similarly, like other self-report measures of health
behavior, self-report of past influenza vaccination status is subject
to recall and social desirability biases. However, there are robust
findings that self-report of influenza vaccination status is quite
accurate for adults [22–24]. Lastly, intention for future influenza
vaccination may not necessarily translate into actual vaccination
and may be sensitive to such changes as fluctuations in the status
of a viral pandemic, as well as other factors (e.g., the severity of the
influenza season).
5. Conclusions
In an online survey, 53% of participants had received the flu vac-
cine in the prior year and 47% had not. Looking to the future, a sig-
nificant subset (25.5%) of participants who had not vaccinated
against influenza in the prior 12 months endorsed an intention
to vaccinate in the upcoming 12 months. In this subset, Hispanic
participants (compared to whites) and individuals who perceived
general benefits from vaccination and COVID-19 as a threat in their
community had increased odds of intending to vaccinate. Among
prior vaccinators, the majority intended to vaccinate again. For
some adults, the COVID-19 pandemic may have served as a ‘‘cue
to action” to intend to vaccinate against influenza. Public health
appeals about influenza vaccination that include community-
referent messages and highlight the potential benefits of vaccina-
tion, including those to the community, may be a useful direction
for further research.
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